The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Study says Britain must vaccinate two million a week to prevent a third COVID-19 wave

Tue, 29th Dec 2020 09:12

(Adds response from UK Health Department)

By Kanishka Singh

Dec 29 (Reuters) - Britain must vaccinate two million people
a week to avoid a third wave of the coronavirus outbreak, a
study by the London School of Hygiene and Tropical Medicine
(LSHTM) has concluded.

The UK has had more than 71,000 deaths from the coronavirus
and over 2.3 million cases of COVID-19 infections as of late
Monday, according to a Reuters tally.

"The most stringent intervention scenario with tier 4
(restrictions) England-wide and schools closed during January
and 2 million individuals vaccinated per week, is the only
scenario we considered which reduces peak ICU (intensive care)
burden below the levels seen during the first wave", the study
said.

"In the absence of substantial vaccine roll-out, cases,
hospitalisations, ICU admissions and deaths in 2021 may exceed
those in 2020."

An accelerated uptake of two million vaccinated per week "is
predicted to have a much more substantial impact", it added https://bit.ly/3o9l2MJ.
The study has yet to be peer-reviewed.

Responding to the study, a UK Health Department spokesman
told Reuters that "over the coming weeks and months the rate of
vaccination will increase as millions more doses become
available and the programme continues to expand."

The British government has said it has secured early access
to 357 million vaccines doses through agreements with several
developers.

Prime Minister Boris Johnson and his scientific advisers
have said a variant of the coronavirus, which could be up to 70%
more transmissible, is spreading rapidly in Britain, although it
is not thought to be more deadly or to cause more serious
illness.

That prompted tight social mixing restriction measures for
London and southeast England, while plans to ease curbs over
Christmas across the nation were dramatically scaled back or
scrapped altogether.

Media reports over the weekend said Britain will roll out
the Oxford-AstraZeneca COVID-19 vaccine from Jan. 4, with
approval by the country's medical regulator expected within
days.

Earlier this month, Britain became the first country in the
world to roll out the vaccine made by Pfizer and
BioNTech.

The British government said on Thursday that 600,000 people
had received the first dose of the Pfizer-BioNTech COVID-19
vaccine.

(Reporting by Kanishka Singh in Bengaluru; Editing by Michael
Perry and Giles Elgood)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.